{"id":"https://openalex.org/W2989776359","doi":"https://doi.org/10.1183/13993003.congress-2019.rct446","title":"Late Breaking Abstract - Identification of patients with COPD who benefit from benralizumab","display_name":"Late Breaking Abstract - Identification of patients with COPD who benefit from benralizumab","publication_year":2019,"publication_date":"2019-09-28","ids":{"openalex":"https://openalex.org/W2989776359","doi":"https://doi.org/10.1183/13993003.congress-2019.rct446","mag":"2989776359"},"language":"en","primary_location":{"id":"doi:10.1183/13993003.congress-2019.rct446","doi":"https://doi.org/10.1183/13993003.congress-2019.rct446","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2019.rct446","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Airway pharmacology and treatment","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009003396","display_name":"Gerard J. Criner","orcid":"https://orcid.org/0000-0003-1267-3483","observed_orcids":["https://orcid.org/0000-0003-1267-3483"]},"institutions":[{"id":"https://openalex.org/I84392919","display_name":"Temple University","ror":"https://ror.org/00kx1jb78","country_code":"US","type":"education","lineage":["https://openalex.org/I84392919"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gerard J. Criner","raw_affiliation_strings":["Lewis Katz School of Medicine, Temple University, Philadelphia, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lewis Katz School of Medicine, Temple University, Philadelphia, United States of America","institution_ids":["https://openalex.org/I84392919"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008555938","display_name":"Bartolom\u00e9 R. Celli","orcid":"https://orcid.org/0000-0002-7266-8371","observed_orcids":["https://orcid.org/0000-0002-7266-8371"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bartolome R. Celli","raw_affiliation_strings":["Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, United States of America","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068917661","display_name":"Dave Singh","orcid":"https://orcid.org/0000-0001-8918-7075","observed_orcids":["https://orcid.org/0000-0001-8918-7075"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Dave Singh","raw_affiliation_strings":["University of Manchester, Manchester University NHS Hospital Trust, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Manchester, Manchester University NHS Hospital Trust, Manchester, United Kingdom","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060008921","display_name":"Maria L. Jison","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria Jison","raw_affiliation_strings":["AstraZeneca, Gaithersburg, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Gaithersburg, United States of America","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021248505","display_name":"Natalya Makulova","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Natalya Makulova","raw_affiliation_strings":["AstraZeneca, Gaithersburg, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Gaithersburg, United States of America","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000491186","display_name":"Vivian H. Shih","orcid":"https://orcid.org/0000-0003-0853-4210","observed_orcids":["https://orcid.org/0000-0003-0853-4210"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vivian H. Shih","raw_affiliation_strings":["AstraZeneca, Gaithersburg, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Gaithersburg, United States of America","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008574089","display_name":"Laura Brooks","orcid":"https://orcid.org/0000-0003-3421-9580","observed_orcids":["https://orcid.org/0000-0003-3421-9580"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura Brooks","raw_affiliation_strings":["AstraZeneca, Gaithersburg, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Gaithersburg, United States of America","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109141543","display_name":"Peter N. Barker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter Barker","raw_affiliation_strings":["AstraZeneca, Gaithersburg, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Gaithersburg, United States of America","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077936927","display_name":"Ubaldo J. Martin","orcid":"https://orcid.org/0000-0002-0089-7677","observed_orcids":["https://orcid.org/0000-0002-0089-7677"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ubaldo J. Martin","raw_affiliation_strings":["AstraZeneca, Gaithersburg, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Gaithersburg, United States of America","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091408306","display_name":"Paul Newbold","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Newbold","raw_affiliation_strings":["AstraZeneca, Gaithersburg, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Gaithersburg, United States of America","institution_ids":["https://openalex.org/I4210150756"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"RCT446","last_page":"RCT446"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/benralizumab","display_name":"benralizumab","score":0.8899999856948853},{"id":"https://openalex.org/keywords/chronic-obstructive-pulmonary-disease","display_name":"chronic obstructive pulmonary disease","score":0.8999999761581421},{"id":"https://openalex.org/keywords/acute-exacerbation-of-copd","display_name":"COPD exacerbations","score":0.9259999990463257},{"id":"https://openalex.org/keywords/blood-eosinophils","display_name":"blood eosinophils","score":0.8379999995231628},{"id":"https://openalex.org/keywords/inhaled-triple-therapy","display_name":"triple inhaled therapy","score":0.7549999952316284},{"id":"https://openalex.org/keywords/frequent-exacerbations","display_name":"frequent exacerbations","score":0.7609999775886536},{"id":"https://openalex.org/keywords/subpopulation-identification","display_name":"subpopulation identification","score":0.4269999861717224}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9241100549697876},{"id":"https://openalex.org/C2779185760","wikidata":"https://www.wikidata.org/wiki/Q3638304","display_name":"Benralizumab","level":5,"score":0.8769305944442749},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7276975512504578},{"id":"https://openalex.org/C2777014857","wikidata":"https://www.wikidata.org/wiki/Q1383410","display_name":"Exacerbation","level":2,"score":0.6079139113426208},{"id":"https://openalex.org/C2776780178","wikidata":"https://www.wikidata.org/wiki/Q199804","display_name":"COPD","level":2,"score":0.6078077554702759},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5734413862228394},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.44217798113822937},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.18131786584854126},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.07839250564575195},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C2777832160","wikidata":"https://www.wikidata.org/wiki/Q3306175","display_name":"Mepolizumab","level":4,"score":0.0},{"id":"https://openalex.org/C2777037409","wikidata":"https://www.wikidata.org/wiki/Q107238","display_name":"Eosinophil","level":3,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2019.rct446","doi":"https://doi.org/10.1183/13993003.congress-2019.rct446","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2019.rct446","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Airway pharmacology and treatment","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2975842537","https://openalex.org/W2946719800","https://openalex.org/W4387979810","https://openalex.org/W4385288317","https://openalex.org/W4313189396","https://openalex.org/W2888063502","https://openalex.org/W2127793095","https://openalex.org/W4410272835","https://openalex.org/W2171875475","https://openalex.org/W4408364378"],"abstract_inverted_index":{"Background:":[0],"In":[1],"GALATHEA/TERRANOVA":[2,45],"Phase":[3,187],"III":[4,188],"trials":[5],"(N":[6],"Engl":[7],"J":[8],"Med.":[9],"2019;":[10],"May":[11],"20),":[12],"exacerbation":[13],"reduction":[14,70],"with":[15,19,77,113,121,136,176],"benralizumab":[16,38,53,78,114,133,184,194],"for":[17,47,119,127,196],"patients":[18,35,48,67,120,175],"COPD":[20,75],"did":[21],"not":[22],"reach":[23],"statistical":[24,59],"significance.":[25],"Aims":[26],"and":[27,150],"Objectives:":[28],"We":[29,41,56,85,170],"evaluated":[30],"baseline":[31,63,88,122,145],"factors":[32,64,109],"to":[33,50,61,73,192],"identify":[34],"demonstrating":[36,68],"greater":[37,69,98,111],"efficacy.":[39],"Methods:":[40],"pooled":[42],"data":[43],"from":[44],"(N=3,910)":[46],"randomized":[49],"placebo":[51,118,163],"or":[52,81],"(56":[54],"weeks).":[55],"ran":[57],"prespecified":[58],"analyses":[60],"detect":[62],"that":[65],"identified":[66,86,110,171],"of":[71,92,139,174],"moderate":[72],"severe":[74],"exacerbations":[76,152],"30":[79],"mg":[80,116,135],"100":[82,115,134],"mg.":[83],"Results:":[84],"several":[87],"efficacy":[89,112,195],"factors:":[90],"history":[91],"frequent":[93],"exacerbations,":[94],"lesser":[95],"post-BD":[96,99],"FEV1,":[97],"FEV1":[100],"response,":[101],"prior":[102,140],"triple":[103,141],"inhaled":[104,142],"therapy":[105,143],"use":[106],"(figure).":[107],"These":[108],"vs.":[117,162],"eosinophils":[123,147],"\u2265220":[124,148],"cells/\u00b5L":[125],"than":[126],"the":[128,157],"overall":[129],"population.":[130],"Patients":[131],"receiving":[132],"a":[137,172,181],"combination":[138],"use,":[144],"blood":[146],"cells/\u00b5L,":[149],"\u22653":[151],"(previous":[153],"12":[154],"months)":[155],"demonstrated":[156,180],"greatest":[158],"response":[159],"(rate":[160],"ratio":[161],"[95%":[164],"CI]:":[165],"0.70":[166],"[0.56,":[167],"0.88]).":[168],"Conclusions:":[169],"subpopulation":[173],"specific":[177],"traits":[178],"who":[179],"clinically":[182],"meaningful":[183],"response.":[185],"A":[186],"trial":[189],"is":[190],"ongoing":[191],"evaluate":[193],"these":[197],"patients.":[198]},"counts_by_year":[],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2019-12-05T00:00:00"}